Internal Medicine, Infectious Disease · Brooklyn, NY
NPI
1265534564
Since 2006
Specialty
Internal Medicine, Infectious Disease
Code 207RI0200X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
240 Willoughby St, Suite 5h
Brooklyn, NY, 11201
Phone (718) 250-6922
Groups this clinician bills Medicare through
Medicare paid, 2024
$30K
460 services
Medicare patients, 2024
162
Average age 68
Drug cost, 2024
$7.9M
7,251 prescriptions
Company payments, 2025
$164
From 5 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Leonard B Berkowitz was code 99214 (office e&m - established), 121 times for 57 patients. In total Leonard B Berkowitz billed 460 services in 25 codes, and Medicare paid $30K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2013-08-07.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Facility | 121 | 57 | $75.07 | $9,084 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 60 | 38 | $13.82 | $829 |
| 99213 Office E&M - Established | Facility | 56 | 41 | $53.29 | $2,984 |
| 99214 Office E&M - Established | Office | 29 | 19 | $99.31 | $2,880 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 27 | 26 | $13.47 | $364 |
| 99213 Office E&M - Established | Office | 22 | 17 | $52.67 | $1,159 |
| G0009 Administration of pneumococcal vaccine | Office | 17 | 17 | $37.09 | $631 |
| 90677 Vaccine Product | Office | 17 | 17 | $220.50 | $3,749 |
| 99221 Hospital E&M - Initial | Facility | 15 | 14 | $71.11 | $1,067 |
| 99203 Office E&M - New | Facility | 14 | 14 | $63.12 | $884 |
| 99204 Office E&M - New | Facility | 12 | 12 | $119.46 | $1,433 |
By year: 2022 $29K for 426 services; 2023 $27K for 420 services; 2024 $30K for 460 services.
Medicare prescription drug claims, 2024
In 2024, the drug Leonard B Berkowitz prescribed most often to Medicare patients was Biktarvy (Bictegrav/Emtricit/Tenofov Ala), with 797 prescriptions and refills. In total Leonard B Berkowitz wrote 7,251 Medicare prescriptions that cost $7.9M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Biktarvy Bictegrav/Emtricit/Tenofov Ala | 797 | 868 | 137 | $3.3M |
| Rosuvastatin Calcium Generic | 320 | 614 | 97 | $2,522 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 260 | 267 | 64 | $8,599 |
| Atorvastatin Calcium Generic | 254 | 508 | 81 | $2,303 |
| Vitamin D2 Ergocalciferol (Vitamin D2) | 203 | 309 | 54 | $318 |
| Odefsey Emtricitab/Rilpiviri/Tenof Ala | 191 | 211 | 28 | $740K |
| Tivicay Dolutegravir Sodium | 158 | 174 | 27 | $419K |
| Gabapentin Generic | 158 | 230 | 40 | $1,611 |
| Amlodipine Besylate Generic | 147 | 320 | 54 | $626 |
| Genvoya Elviteg/Cob/Emtri/Tenof Alafen | 147 | 151 | 28 | $586K |
| Losartan Potassium Generic | 139 | 249 | 41 | $762 |
| Dovato Dolutegravir Sodium/Lamivudine | 139 | 151 | 21 | $427K |
| Descovy Emtricitabine/Tenofov Alafenam | 134 | 158 | 19 | $333K |
| Ezetimibe Generic | 122 | 244 | 36 | $1,691 |
| Juluca Dolutegravir/Rilpivirine | 115 | 117 | 21 | $392K |
Brand drugs: 2,995 claims; generic drugs: 4,135 claims; opioid claims: 131.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Leonard B Berkowitz $164 ($164 in general payments such as food, travel and fees) from 5 companies. The largest payer was ViiV Healthcare Company with $49.08.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.